Stay up to date

Latest press releases

View more press releases

07/29/2024

Applications for the Dr. Fritz-Wörwag Research Prize 2024/25

In order to support research and science, Wörwag Pharma announces the 11th Dr. Fritz-Wörwag Research Prize 2024/25.

Read press information

02/22/2024

Wörwag Pharma: success instead of bottle necks

Böblingen, February 22, 2024 – Wörwag Pharma closed the 2023 financial year with an organic sales growth of 7.6 percent – despite the tense situation…

Read press information

01/22/2024

Mauermann becomes Wörwag Pharma Production

Böblingen, January 22, 2024 – With the renaming of the most recent investment Mauermann Arzneimittel GmbH & Co. KG, Wörwag Pharma is taking the next…

Read press information

09/19/2023

Wörwag Pharma acquires Mauermann-Arzneimittel KG

Böblingen, September 19, 2023 – Wörwag Pharma is taking over contract manufacturer Mauermann-Arzneimittel KG with immediate effect. The…

Read press information

03/16/2023

Wörwag Pharma invests in further growth

Böblingen, March 16, 2023 – The Böblingen-based pharmaceutical and family-owned company Wörwag Pharma closed the 2022 financial year with an increase…

Read press information

02/13/2023

Changes to Wörwag Pharma's Advisory Board

Böblingen, February 13, 2023 – The shareholders' meeting of the Wörwag Pharma Group has elected a new Advisory Board: With Konstantin von Alvensleben…

Read press information

Your contact persons

Monika Wörwag

Director Corporate Communications

press@woerwagpharma.com

Kerstin Imbery-Will

Specialist and Product Communications

press@woerwagpharma.com

Information for media representatives

Journalists and editors may use the images available here free of charge and for editorial purposes only, provided they cite "Wörwag Pharma" as the source. Graphic changes are not permitted. Please send your free specimen copies to press@woerwagpharma.com.